Cytomedix, FDA Clearance For AutoloGel

Sep. 20, 2007 – Cytomedix, Inc. (AMEX: GTF) today announced that the FDA has granted marketing clearance for the AutoloGelTM System. The indications for use are as follows:
Under the supervision of a healthcare professional, the PRP gel produced by the AutoloGel™ System is suitable for exuding wounds, such as leg ulcers, pressure ulcers, diabetic ulcers and for the management of mechanically or surgically-debrided wounds... Cytomedix's Press Release -